claim_id	core_finding	estimand	tier_target	tier_current	semantic_boundary	forbidden_implications	protocol_section	key_output_tables	evidence_modules	primary_dataset	validation_dataset
C1_CIGIB_STRICT	PPI vs H2RA changes 14-day risk of strict CIGIB	Effect of initiating PPI (vs H2RA) within 0-24h on 14-day risk of strict CIGIB (time zero at ICU+24h)	Target trial emulation (observational causal under assumptions)	DRAFT	Allowed: "associated with" / "consistent with a causal effect under TTE assumptions"; report effect sizes + CI; emphasize residual confounding possible. Not allowed: definitive causality claims.	proves causation; establishes superiority; clinical recommendation; guideline-level claims	Protocol 1, 3-7 (estimands, eligibility, exposure, outcomes, analysis)	output/multicohort_run/combined/effect_estimates_combined.csv; output/multicohort_run/mimic/tables/balance_smd.csv; output/multicohort_run/mimic/tables/table1.csv; output/multicohort_run/mimic/audit/run_audit.json	IPTW balance diagnostics; sensitivity suite (planned); external validation	mimic	eicu
C2_CDI	PPI vs H2RA changes 14-day risk of CDI	Effect of initiating PPI (vs H2RA) within 0-24h on 14-day CDI risk (time zero at ICU+24h)	Target trial emulation (observational causal under assumptions)	DRAFT	Allowed: effect estimates with uncertainty; acknowledge outcome ascertainment limitations. Not allowed: mechanistic claims.	proves causation; mechanistic claims; clinical recommendation	Protocol 1, 4, 6-7 (secondary outcomes, analysis, sensitivity)	output/multicohort_run/combined/effect_estimates_combined.csv; output/multicohort_run/mimic/audit/run_audit.json	Sensitivity on outcome definitions (planned); negative-control window (planned); external validation	mimic	eicu
C3_MORTALITY	PPI vs H2RA changes 28-day (or in-hospital) mortality	Effect of initiating PPI (vs H2RA) within 0-24h on 28-day (or in-hospital) all-cause mortality (time zero at ICU+24h)	Target trial emulation (observational causal under assumptions)	DRAFT	Allowed: cautious interpretation; highlight competing risks and residual confounding. Not allowed: claims of benefit/harm without robustness.	proves causation; treatment recommendation; claims beyond observed follow-up	Protocol 1, 4, 6-7 (mortality, analysis, sensitivity)	output/multicohort_run/combined/effect_estimates_combined.csv; output/multicohort_run/mimic/audit/run_audit.json	Competing-risk sensitivity (planned); external validation	mimic	eicu
